Monitoring Your Exercise-related Metrics Over Time Via Wearable Electronic Devices
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- M.D. Anderson Cancer Center
- Enrollment
- 35
- Locations
- 1
- Primary Endpoint
- To evaluate the feasibility of the ( PA) Physical Activity intervention.
- Status
- Active, not recruiting
- Last Updated
- 5 months ago
Overview
Brief Summary
To test the use of a continuous activity and heart rate tracker (Fitbit) and continuous glucose monitor (CGM) in monitoring daily exercise-related activities.
Detailed Description
Primary objective: To evaluate the feasibility of a CGM-based physical activity intervention that includes the use of CGM and Fitbit®. Secondary objectives: To examine changes in physical activity motivation and other related psychosocial variables (e.g., intention, perceived benefits, outcome expectancy) before and after the intervention. Exploratory objective: Examine cancer-related biomarkers and their associations with daily glucose pattern.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Men and women at least 18 years old
- •Body mass index (BMI) 25 kg/m2
- •Engage in less than 150 minutes of moderate-intensity PA per week in the past month
- •Capable of participating in moderate-vigorous unsupervised exercise (as determined by the Physical Activity Readiness Questionnaire (PARQ) or a medical release from their physician)
- •Self-reported ability to walk one block without pain or discomfort
- •Have a smart phone with daily internet access that is compatible with the LibreLink app
- •Ability to speak, read, and write in English
- •For the cancer survivor cohort (participant accession number #21 and beyond), individuals must have been diagnosed with stage I-III breast or colorectal cancer and completed adjuvant therapy (i.e., chemo and/or radiation therapy).
Exclusion Criteria
- •Self-reported current diagnosis or history of type 1 diabetes or type 2 diabetes
- •Self-reported use of oral antidiabetic agents (OADs)
- •Previous or current treatment with any insulin regimen other than basal insulin, e.g. prandial or pre-mixed insulin (short term treatment due to intercurrent illness including gestational is allowed at the discretion for the investigator)
- •Current use of a continuous glucose monitor
- •Fasting glucose \> 125 mg/dL
- •Pregnancy
- •Self-reported health issues that limit physical activity
- •On dialysis
- •Work overnight shifts
- •Unwilling to use CGM
Outcomes
Primary Outcomes
To evaluate the feasibility of the ( PA) Physical Activity intervention.
Time Frame: through study completion, an average of 1 year
The use of CGM through the following criteria: CGM-specific refusal rate \<20% at the participant recruitment phase and protocol adherence rates \>80% at the end of the monitoring period.